Complete remission in the nephrotic syndrome study network

Clinical Journal of the American Society of Nephrology

Volumn 11, Issue 1, 2016, Pages 81-89

  Gipson, Debbie S ^a   Troost, Jonathan P ^a   Lafayette, Richard A ^a   Hladunewich, Michelle A ^a   Trachtman, Howard ^a   Gadegbeku, Crystal A ^a   Sedor, John R ^a   Holzman, Lawrence B ^a   Moxey Mims, Marva M ^a   Perumal, Kalyani ^a   Kaskel, Frederick J ^a   Nelson, Peter J ^a   Tuttle, Katherine R ^a   Bagnasco, Serena M ^a   Hogan, Marie C ^a   Dell, Katherine M ^a   Appel, Gerald B ^a   Lieske, John C ^a   Ilori, Titilayo O ^a   Sethna, Christine B ^a   Fervenza, Fernando C ^a   Hogan, Susan L ^a   Nachman, Patrick H ^a   Rosenberg, Avi Z ^a   Greenbaum, Larry A ^a   Meyers, Kevin E C ^a   Hewitt, Stephen M ^a   Choi, Michael J ^a   Kopp, Jeffrey B ^a   Zhdanova, Olga ^a   Hodgin, Jeffrey B ^a   Johnstone, Duncan B ^a   Adler, Sharon G ^a   Avila Casado, Carmen ^a   Neu, Alicia M ^a   Hingorani, Sangeeta R ^a   Lemley, Kevin V ^a   Nast, Cynthia C ^a   Brady, Tammy M ^a   Barisoni Thomas, Laura ^a   Fornoni, Alessia ^a   Jennette, J Charles ^a   Cattran, Daniel C ^a   Palmer, Matthew B ^a   Gibson, Keisha L ^a   Reich, Heather N ^a   Mokrzycki, Michele H ^a   Sambandam, Kamalanathan K ^a   Zilleruelo, Gaston E ^a   Licht, Christoph ^a   Sampson, Matthew G ^a   Song, Peter ^a   Mariani, Laura H ^a   Kretzler, Matthias ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CREATININE; CYCLOPHOSPHAMIDE; MYCOPHENOLATE MOFETIL; RITUXIMAB;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; END STAGE RENAL DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; NEPHROTIC SYNDROME; PROTEINURIA; REMISSION; VERY ELDERLY; BIOPSY; CLINICAL TRIAL; COHORT ANALYSIS; COMPLICATION; FEMALE; GLOMERULUS FILTRATION RATE; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATHOLOGY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; BIOPSY; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; OUTCOME ASSESSMENT (HEALTH CARE); PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROTEINURIA; REMISSION INDUCTION;

EID: 84954456042     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02560315     Document Type: Article

References (17)

1. US Renal Data System: USRDS 2014 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, 2014
2. Gadegbeku CA, Gipson DS, Holzman LB, Ojo AO, Song PX, Barisoni L, Sampson MG, Kopp JB, Lemley KV, Nelson PJ, Lienczewski CC, Adler SG, Appel GB, Cattran DC, Choi MJ, Contreras G, Dell KM, Fervenza FC, Gibson KL, Greenbaum LA, Hernandez JD, Hewitt SM, Hingorani SR, Hladunewich M, Hogan MC, Hogan SL, Kaskel FJ, Lieske JC, Meyers KE, Nachman PH, Nast CC, Neu AM, Reich HN, Sedor JR, Sethna CB, Trachtman H, Tuttle KR, Zhdanova O, Zilleruelo GE, Kretzler M: Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int 83: 749-756, 2013
3. Barisoni L, Nast CC, Jennette JC, Hodgin JB, Herzenberg AM, Lemley KV, Conway CM, Kopp JB, Kretzler M, Lienczewski C, Avila-Casado C, Bagnasco S, Sethi S, Tomaszewski J, Gasim AH, Hewitt SM: Digital pathology evaluation in the multicenter Nephrotic Syndrome Study Network (NEPTUNE). Clin J Am Soc Nephrol 8: 1449-1459, 2013
4. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972
5. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
6. Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL: New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20: 629-637, 2009
7. th Ed., edited by Gilbert S, Weiner DE, Philadelphia, Saunders, 2013, pp 152-163
8. Nawaz Z, Mushtaq F, Mousa D, Rehman E, Sulaiman M, Aslam N, Khawaja N: Pattern of glomerular disease in the Saudi population: A single-center, five-year retrospective study. Saudi J Kidney Dis Transplant 24: 1265-1270, 2013
9. Sugiyama H, Yokoyama H, Sato H, Saito T, Kohda Y, Nishi S, Tsuruya K, Kiyomoto H, Iida H, Sasaki T, Higuchi M, Hattori M, Oka K, Kagami S, Kawamura T, Takeda T, Hataya H, Fukasawa Y, Fukatsu A, Morozumi K, Yoshikawa N, Shimizu A, Kitamura H, Yuzawa Y, Matsuo S, Kiyohara Y, Joh K, Nagata M, Taguchi T, Makino H; Committee for Standardization of Renal Pathological Diagnosis; Committee for Kidney Disease Registry; Japanese Society of Nephrology: Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee report for 2009 and 2010. Clin Exp Nephrol 17: 155-173, 2013
10. McQuarrie EP, Mackinnon B, Young B, Yeoman L, Stewart G, Fleming S, Robertson S, Simpson K, Fox J, Geddes CC; Scottish Renal Biopsy Registry: Centre variation in incidence, indication and diagnosis of adult native renal biopsy in Scotland. Nephrol Dial Transplant 24: 1524-1528, 2009
11. Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC; Toronto Glomerulonephritis Registry Group: Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. J Am Soc Nephrol 16: 1061-1068, 2005
12. Bazzi C, Rizza V, Casellato D, Stivali G, Rachele G, Napodano P, Gallieni M, D’Amico G: Urinary IgG and alpha2-macroglobulin are powerful predictors of outcome and responsiveness to steroids and cyclophosphamide in idiopathic focal segmental glomerulosclerosis with nephrotic syndrome. Biomed Res Int 2013: 941831, 2013
13. Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, D’Agati V, Appel G: Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol 2: 445-453, 2007
14. Yamaguchi M, Ando M, Yamamoto R, Akiyama S, Kato S, Katsuno T, Kosugi T, Sato W, Tsuboi N, Yasuda Y, Mizuno M, Ito Y, Matsuo S, Maruyama S: Patient age and the prognosis of idiopathic membranous nephropathy. PLoS One 9: e110376, 2014
15. Kopp JB, Winkler CA, Zhao X, Radeva MK, Gassman JJ, D’Agati VD, Nast CC, Wei C, Reiser J, Guay-Woodford LM, Pollak MR, Hildebrandt F, Moxey-Mims M, Gipson DS, Trachtman H, Friedman AL, Kaskel FJ; FSGS-CT Study Consortium: Clinical features and histology of apolipoprotein L1-associated nephropathy in the FSGS clinical trial. J Am Soc Nephrol 26: 1443-1448, 2015
16. Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A, Bekele E, Bradman N, Wasser WG, Behar DM, Skorecki K: Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet 128: 345-350, 2010
17. Sampson MG, Robertson CC, Martini S, Mariani LH, Lemley KV, Gillies CE, Otto EA, Kopp JB, Randolph A, Vega-Warner V, Eichinger F, Nair V, Gipson DS, Cattran DC, Johnstone DB, O’Toole JF, Bagnasco SM, Song PX, Barisoni L, Troost JP, Kretzler M, Sedor JR; and the Nephrotic Syndrome Study Network: Integrative genomics identifies novel associations with APOL1 risk genotypes in black NEPTUNE subjects [published online ahead of print July 6, 2015]. J Am Soc Nephrol doi: 10.1681/ASN.2014111131